Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
The Institute of Molecular and Translational Medicine, Czech Republic
Boston Children's Hospital
University Health Network, Toronto
Jewish General Hospital
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
University of Southern California
CHA University
SOLTI Breast Cancer Research Group
University Hospital, Montpellier
Huashan Hospital
SOLTI Breast Cancer Research Group
Helse Nord-Trøndelag HF
Ludwig-Maximilians - University of Munich
Fundacion Clinic per a la Recerca Biomédica
Fundacion Clinic per a la Recerca Biomédica
University of Arizona
Australian & New Zealand Children's Haematology/Oncology Group
Karolinska University Hospital
University Hospital, Montpellier
Oncology Institute of Southern Switzerland
University of Milano Bicocca
Centro di Riferimento Oncologico - Aviano
Nanfang Hospital, Southern Medical University
Centro di Riferimento Oncologico - Aviano
Post Graduate Institute of Medical Education and Research, Chandigarh
Nanfang Hospital, Southern Medical University
Nanfang Hospital, Southern Medical University
Parc de Salut Mar
Peking University People's Hospital
Istituto Clinico Humanitas
Istituto Clinico Humanitas
Fondazione del Piemonte per l'Oncologia
University of Roma La Sapienza
National Health Research Institutes, Taiwan